Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likelyExtremely likely
(Optional)
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H
2591Health technology
$2.2B
Market Cap
Shariah Analysis
TBD
Business
Cash
Liabilities
Based on AAOIFI screening standards, Guangzhou Innogen Pharmaceutical Group Co Ltd Class H appears to be TBD.
Business Activity
Revenue breakdown data currently unavailable.
Financial Screening
FYE 2024
Cash (<30%)0.00%
Non-Shariah Cash Items
Cash And Cash Equivalents$526.5M
Other Short Term Investments$270.3M
Restricted Cash-
Liabilities (<30%)0.00%
Non-Shariah Liabilities
Current Capital Lease Obligation-
Long Term Capital Lease Obligation-
Current Debt$9.9M
Market Data
Exchange
HKEX
CurrencyUSD
CountryHong Kong
Last Updated2025-12-15
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.
HKEX
